(Total Views: 784)
Posted On: 05/15/2024 11:19:19 PM
Post# of 148870
An article entitled "Clinical and CSF single-cell profiling of post-COVID-19 cognitive impairment" was posted on 5/13/24 in Cell Reports Medicine Journal.
Highlights:
• Improvement from post-COVID-19 cognitive impairment (CI) is slow
• Post-COVID-19 CI is molecularly distinct from Alzheimer’s disease
• Post-COVID-19 CI is associated with CSF monocyte recruitment and gene alterations
• Improvement from post-COVID-19 CI is linked to greater CSF interferon responses
https://www.cell.com/cell-reports-medicine/fu...24)00253-2
Very technical and lengthy article.
ohm, if you see anything relevant re Leronlimab, please let us know.
Highlights:
• Improvement from post-COVID-19 cognitive impairment (CI) is slow
• Post-COVID-19 CI is molecularly distinct from Alzheimer’s disease
• Post-COVID-19 CI is associated with CSF monocyte recruitment and gene alterations
• Improvement from post-COVID-19 CI is linked to greater CSF interferon responses
https://www.cell.com/cell-reports-medicine/fu...24)00253-2
Very technical and lengthy article.
ohm, if you see anything relevant re Leronlimab, please let us know.
(8)
(0)Scroll down for more posts ▼
